Skip to main content
Glama

Figshare

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the annotations (readOnlyHint, idempotentHint, etc.), the description discloses valuable behavior: graceful degradation of LEI/FIGI enrichment, internal cascading lookups, explicit 'unresolved' field, and the figi_candidates mechanism. There is no contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is dense and front-loaded with the core purpose and usage. It is long but every sentence contributes value; minor redundancy in the long list of query examples could be trimmed, but overall structure is clear.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description compensates by explaining return behaviors, edge cases (unresolved identifiers), and degradation scenarios. It fully prepares an agent to invoke the tool correctly and interpret results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description adds crucial semantic detail: examples for ticker/CIK/ISIN/names, warning against passing full noun phrases, and explanation of ISIN-to-LEI mapping. It significantly enriches the schema definitions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: resolving a user-spoken NAME to canonical/official identifiers. It gives specific verb ('resolve') and resource (identifiers), and lists supported types ('company', 'drug') with details, distinguishing it from siblings like compare_entities and entity_profile.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description provides explicit when-to-use guidance: 'Use FIRST whenever you have a name but need an ID.' It also explains behavior when ambiguous ('asserts nothing and returns figi_candidates'), but does not explicitly name alternative tools or conditions when NOT to use, so a small gap remains.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Figshare toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tools overlap heavily: ask_pipeworx and ask_pipeworx_beta are documented as currently identical, ask_pipeworx_grounded/deep_research route the same class of questions, and the six polymarket_* tools plus bet_research form a confusing cluster. Some clusters (Figshare fetch/search, memory, subscriptions) are distinct, but overall boundaries are frequently unclear.

Naming Consistency4/5

Names are uniformly lowercase snake_case and mostly follow a predictable verb_noun pattern (ask_pipeworx, list_subscriptions, resolve_entity, scan_dependency). The main inconsistency is the mix of bare-noun Figshare resource names (article, articles, collection, collections) with verb-phrase tool names.

Tool Count2/5

38 tools is well above the comfortable scope for a coherent server, especially one named Figshare. Most of the surface is unrelated to Figshare, bundling Pipeworx research, Polymarket analysis, memory, subscriptions, AI visibility, and npm checks into a single connection.

Completeness2/5

The Figshare read-side is reasonably covered (search, article metadata, files, collections, categories, licenses), but there are no create/update/delete or account/upload operations. The broader advertised surface is a grab bag with no clear domain boundary, and several subdomains are shallow while prediction markets are over-represented.

Resources